AU2003288908A1 - Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) - Google Patents

Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr)

Info

Publication number
AU2003288908A1
AU2003288908A1 AU2003288908A AU2003288908A AU2003288908A1 AU 2003288908 A1 AU2003288908 A1 AU 2003288908A1 AU 2003288908 A AU2003288908 A AU 2003288908A AU 2003288908 A AU2003288908 A AU 2003288908A AU 2003288908 A1 AU2003288908 A1 AU 2003288908A1
Authority
AU
Australia
Prior art keywords
pbr
identification
peripheral
benzodiazepine receptor
polypeptide antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288908A
Other versions
AU2003288908A8 (en
Inventor
Maria Gazouli
Vassilios Papadopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU2003288908A8 publication Critical patent/AU2003288908A8/en
Publication of AU2003288908A1 publication Critical patent/AU2003288908A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003288908A 2002-10-01 2003-09-23 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) Abandoned AU2003288908A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41463502P 2002-10-01 2002-10-01
US60/414,635 2002-10-01
PCT/US2003/029822 WO2004031722A2 (en) 2002-10-01 2003-09-23 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr)

Publications (2)

Publication Number Publication Date
AU2003288908A8 AU2003288908A8 (en) 2004-04-23
AU2003288908A1 true AU2003288908A1 (en) 2004-04-23

Family

ID=32069744

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288908A Abandoned AU2003288908A1 (en) 2002-10-01 2003-09-23 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr)

Country Status (2)

Country Link
AU (1) AU2003288908A1 (en)
WO (1) WO2004031722A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055036A1 (en) * 2007-03-12 2010-03-04 National Institute of Radiolotgical Sciences Pet visualization of amyloid-associated neuroinflammation in the brain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550124A (en) * 1991-12-10 1996-08-27 University Of Southern California Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease

Also Published As

Publication number Publication date
WO2004031722A3 (en) 2005-02-03
AU2003288908A8 (en) 2004-04-23
WO2004031722A2 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2003231513A1 (en) Pgd2 receptor antagonist
AU2003261392A1 (en) M3muscarinic acetylcholine receptor antagonists
AU2003243497A1 (en) Antagonists of melanin concentrating hormone receptor
AU2003241836A1 (en) Lpa receptor antagonists
AU2003238833A1 (en) Deployable telemedicine system
EP1539766A4 (en) Calcitonin gene related peptide receptor antagonists
AU2003268767A1 (en) Ea member attaching construction
IL165841A0 (en) Mchir antagonists
EP1463759B8 (en) Ligand for g-protein coupled receptor gpr43 and uses thereof
AU2003251739A1 (en) New neuropeptide y y5 receptor antagonists
AU2003255501A1 (en) Cxcr4 receptor antagonists
PL373007A1 (en) Novel antagonists of mcp proteins
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2003236247A1 (en) Bombesin antagonists
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
AU2003260072A1 (en) Antagonists of chemokine receptors
AU2003286251A1 (en) New bicyclic angiotensin ii agonists
AU2003240705A1 (en) Morpholinylmethylureas ccr-3 receptor antagonists
AU2003300904A1 (en) Antagonists for human prolactin
AU2003291400A1 (en) Assay for autoantibodies to folate receptors
AU2003223785A1 (en) Adapter deployment without recycle
AU2002359524A1 (en) P2x7 receptor antagonists
AU2003288908A1 (en) Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr)
AU2003223329A1 (en) Antagonists of rf-amide neuropeptides
AU2003240730A1 (en) Morpholinylmethylureas ccr-3 receptor antagonist

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase